Traffic of JC virus from sites of initial infection to the brain: The path to progressive multifocal leukoencephalopathy

Journal of Infectious Diseases

Volumn 186, Issue SUPPL. 2, 2002, Pages

  Sabath, Bruce F ^a   Major, Eugene O ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; RNA; VIRUS DNA;

ANTIBODY DETECTION; BINDING SITE; BRAIN INFECTION; CELL SURFACE; CELL TYPE; CONFERENCE PAPER; DEMYELINATING DISEASE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; JC VIRUS; LATENT PERIOD; MEDICAL RESEARCH; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM; VIRUS REACTIVATION;

BRAIN; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 0036891078     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344280     Document Type: Conference Paper

References (53)

1. Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leukoencephalopathy. Brain 1958; 81:93-127.
2. Hallervorden J. Eigennartige und nicht rubriziebare Prozesse. In: Bumke O, ed. Handbuch der Geiteskranheiten. Vol 2. Die Anatomie der Psychosen. Berlin: Springer, 1930:1063-107.
3. Cavanaugh JB, Greenbaum D, Marshall A, et al. Cerebral demyelination associated with disorders of reticuloendothelial system. Lancet 1959;2:524-9.
4. ZuRhein GM. Ultrastructural studies in progressive multifocal leukoencephalopathy, a demyelinating disease of man of probable viral etiology. Int Arch Allergy Appl Immunol 1969; 36(Suppl):463-87.
5. Padgett BL, ZuRhein GM, Walker DL, Eckroade RJ. Cultivation of papovalike virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971; 1:1257-60.
6. Ledoux S, Libman I, Robert F, Just N. Progressive multifocal leukoencephalopathy with gray matter involvement. Can J Neurol Sci 1989; 16:200-2.
7. Kepes JJ, Chou SM, Price LW Jr. Progressive multifocalleukoencephalopathy with 10 year survival in a patient with nontropical sprue: Report of a case with unusual light and electron microscopic features. Neurology 1975; 25:1006-12.
8. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992; 5:49-73.
9. Brown P, Tsai T. Gadjusek C. Seroepidemiology of human papovaviruses: Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 1975; 102:331-40.
10. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973; 127:467-70.
11. Tornatore C, Amemiya K, Atwood W, Conant K, Major EO, Berger J. JC virus - Current concepts and controversies in the molecular virology and pathogenesis of progressive multifocal leukoencephalopathy. Rev Med Virol 1994; 4:197-219.
12. Major EO. Human polyomavirus. In: Knipe DM, Howley PM, Griffin DE, et al, eds. Fields Virology. 4th Ed. Vol 2. New York: Lippincott. 2001:2175-96.
13. London WT, Houff SA, Madden DL, et al. Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 1978; 201:1246-9.
14. Walker DL, Padgett BL, ZuRhein GM, Albert AE, Marsh RF. Human papovavirus (JC): Induction of brain tumors in hamsters. Science 1973; 181:674-6.
15. Frisque, RJ. Structure and function of JC virus T proteins. J Neurovirol 2001; 7:293-7.
16. Safak M, Barrucco R, Darbinyan A, Okada Y, Nagashima K, Khalili K. Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol 2001; 75:1476-86.
17. Jensen PN, Major EO. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol 2001; 7:280-7.
18. Vacante DA, Traub R, Major EO. Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 1989; 170:353-61.
19. Martin JD, King DM, Slauch JM, Frisque RJ. Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 1985; 53:306-11.
20. Ault GS. Activity of JC virus archetype and PML-type regulatory regions in glial cells. J Gen Virol 1997; 78:163-9.
21. ZuRhein GM. Particles resembling papovavirions in human cerebral demyelinating disease. Science 1965; 148:1477-9.
22. Wroblewska Z, Wellish M, Bilden D. Growth of JC virus in adult human brain cell cultures. Arch Virol 1980;65:141-8.
23. Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci USA 1985; 82:1257-61.
24. Monaco MC, Atwood WJ, Gravell M, Tornatore C, Major EO. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: Implications for viral latency. J Virol 1996; 70:7004-12.
25. Liu CK, Wei G, Atwood WJ. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal α(2-6)-linked sialic acids. J Virol 1998; 72:4643-9.
26. Wei G, Lui CK, Atwood WJ. JC virus bind to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T-lymphocytes. J Neurovirol 2000; 6:127-36.
27. Raj GV, Khalili K. Transcriptional regulation: Lessons from the human neurotropic polyomavirus, JCV. Virology 1995; 213:283-91.
28. Ranganathan PN, Khalili K. The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 1993; 21:1959-64.
29. Kerr D, Chang CF, Chen N, et al. Transcription of a human neurotropic virus promoter in glial cells: Effect of YB-1 on expression of the JC virus late gene. J Virol 1994; 68:7637-43.
30. Chen NN, Khalili K. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Purα in glial cells. J Virol 1995;69:5843-8.
31. Wegner M, Drolet DW, Rosenfeld MG. Regulation of JC virus by the POU-domain transcription factor Tst-1: Implications for progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 1993;90:4743-7.
32. Amemiya K, Traub R, Durham L, Major EO. Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes. J Biol Chem 1992:267:14204-11.
33. Amemiya K, Traub R, Durham L, Major EO. Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 1989; 264:7025-32.
34. Sumner C, Shinohara T, Durham L, Traub R, Major EO. Amemiya K. Expression of multiple classes of the nuclear factor-1 family in the developing human brain: Differential expression of two classes of NF-1 genes. J Neurovirol 1996;2:87-100.
35. Monaco MCG, Sabath BF, Durham LC, Major EO. JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. J Virol 2001; 75:9687-95.
36. Pfister LA, Letvin NL, Koralnik IJ. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol 2001; 75:5672-6.
37. Daniel AM, Swenson JJ, Mayreddy RP, Khalili K, Frisque RJ. Sequences within the early and the late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 1996;216:90-101.
38. Sandler ES, Aquino VM, Goss-Shohet E, Hinrichs S, Krisher K, BK papova virus pneumonia following hematopoietic stem cell transplantation. Bone Marrow Transplant 1997; 20:163-5.
39. Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10:91-9.
40. Anagnostopoulos 1, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus. Blood 1995; 85:744-50.
41. Monaco MCG, Jensen PN, Hou J, Durham LC, Major EO. Detection of JC virus DNA in human tonsil tissue: Evidence for site of initial viral infection. J Virol 1998; 72:9918-23.
42. Pho MT, Ashok A, Atwood WJ. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol 2000; 74:2288-92.
43. Lisignoli G, Monaco MC, Facchini A. et al. In vitro cultured stromal cells from human tonsils display a distinct phenotype and induce B cell adhesion and proliferation. Eur J Immunol 1996;26:17-27.
44. Yogo Y, Kitamura T, Sugimoto C, et al. Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients. J Virol 1991;65:2422-8.
45. Houff SA, Major EO, Katz DA, et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 1988; 318:301-5.
46. Tornatore C, Berger JR, Houff SA, et al. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 1992; 31:454-62.
47. Schneider EM, Dorries K. High frequency of polyomavirus infection in lymphoid cell preparations after allogenic bone marrow transplantation. Transplant Proc 1993;25:1271-3.
48. Dorries K, Vogel E, Gunther S, Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994;198:59-70.
49. Atwood WJ, Amemiya K, Traub R. Harms J, Major EO. Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 1992; 190:716-23.
50. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147:676-82.
51. Weber T, Major EO. Progressive multifocal leukoencephalopathy: Molecular biology, pathogenesis, and clinical impact. Intervirology 1997; 40:98-111.
52. Hickey WF. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1991; 1:97-105.
53. Major EO, Amemiya K. Elder G, Houff SA. Gilal cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus. JCV. J Neurosci Res 1990;27:461-71.